U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07909772) titled 'Effects of a Multispecies Probiotic on Metabolic, Liver, and Gut Health' on Oct. 14.
Brief Summary: The goal of this clinical trial is to learn if multistrain probiotic works to improve severe metabolic markers and gastrointestinal symptoms in obese MASLD patients. The main questions it aims to answer are
Does this multistrain probiotic improve the composition of gut microbiota? Does it improve gastrointestinal symptoms and metablic profiles? Does it help in improving the grade of liver steatosis, and lose weight? Researchers will compare a multistrain probiotic group to a control group.
Participants will:
The probiotic group will...